Metabolism and neurotoxicity of homocysteine thiolactone in mice: Evidence for a protective role of paraoxonase 1

Journal of Alzheimer's Disease

Volumn 30, Issue 2, 2012, Pages 225-231

  Borowczyk, Kamila ^a,e   Shih, Diana M ^b   Jakubowski, Hieronim ^a,c,d  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c INSTITUTE OF BIOORGANIC CHEMISTRY   (Poland)

^d POZNA UNIVERSITY OF LIFE SCIENCES   (Poland)

^e UNIVERSITY OF LODZ   (Poland)

Author keywords

Alzheimer's disease; homocysteine thiolactone; neurotoxicity; Pon 1

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; HOMOCYSTEINE THIOLACTONE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; HYDROLYSIS; IN VIVO STUDY; MOUSE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; SEIZURE; TOXIN HYDROLYSIS;

EID: 84861524089     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-111940     Document Type: Article

References (34)

1. Mudd SH, Levy HL, Krauss JP (2001) Disorders of transsul-furation. In: The metabolic and molecular bases of inherited disease, Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler KW, Vogelstein B, eds., Mc Graw-Hill, New York, pp. 2007-2056.
2. Jakubowski H, Goldman E (1993) Synthesis of homocys-teine thiolactone by methionyl-tRNA synthetase in cultured mammalian cells. FEBS Lett 317, 237-240. (Pubitemid 23045796)
3. Jakubowski H (1999) Protein homocysteinylation: Possible mechanism underlying pathological consequencesofelevated homocysteine levels. FASEB J 13, 2277-2283.
4. Chwatko G, Boers GH, Strauss KA, Shih DM, Jakubowski H (2007) Mutations in methylenetetrahydrofolate reductase or cystathionine beta-synthase gene, or a high-methionine diet, increase homocysteine thiolactone levels inhumans and mice. FASEB J 21, 1707-1713. (Pubitemid 46855616)
5. Jakubowski H, Boers GH, Strauss KA (2008) Mutations in cystathionine beta-synthase or methylenetetrahydrofolate reductase gene increase N-homocysteinylated protein levels in humans. FASEB J 22, 4071-4076.
6. Jakubowski H, Perla-Kajan J, Finnell RH, Cabrera RM, Wang H, Gupta S, Kruger WD, Kraus JP, Shih DM (2009) Genetic or nutritional disorders in homocysteine or folate metabolism increase protein N-homocysteinylation in mice. FASEB J 23, 1721-1727.
7. Glowacki R, Jakubowski H (2004) Cross-talk between Cys34 and lysine residues in human serum albumin revealed by N-homocysteinylation. J Biol Chem 279, 10864-10871. (Pubitemid 38401576)
8. Sibrian-Vazquez M, Escobedo JO, Lim S, Samoei GK, Stron-gin RM (2010) Homocystamides promote free-radical and oxidative damage to proteins. Proc Natl Acad Sci USA 107, 551-554.
9. Paoli P, Sbrana F, Tiribilli B, Caselli A, Pantera B, Cirri P, De Donatis A, Formigli L, Nosi D, Manao G, Camici G, Ramponi G (2010) Protein N-homocysteinylation induces the formation of toxic amyloid-like protofibrils. J Mol Biol 400, 889-907.
10. Perla-Kajan J, Stanger O, Luczak M, Ziolkowska A, Malendowicz LK, Twardowski T, Lhotak S, Austin RC, Jakubowski H (2008) Immunohistochemical detection of N-homocysteinylated proteins in humans and mice. Biomed Pharmacother 62, 473-479.
11. Suszynska J, Tisonczyk J, Lee HG, Smith MA, Jakubowski H (2010) Reduced homocysteine-thiolactonase activity in Alzheimer's disease. J Alzheimers Dis 19, 1177-1183.
12. Smith AD, Smith SM, de Jager CA, Whitbread P, Johnston C, Agacinski G, Oulhaj A, Bradley KM, Jacoby R, Refsum H (2010) Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: A randomized controlled trial. PLoS One 5, e12244.
13. Marsillach J, Mackness B, Mackness M, Riu F, Beltran R, Joven J, Camps J (2008) Immunohistochemical analysis of paraoxonases-1, 2, and 3 expression in normal mouse tissues. Free Radic Biol Med 45, 146-157.
14. Shih DM, Gu L, Xia YR, Navab M, Li WF, Hama S, Castel-lani LW, Furlong CE, Costa LG, Fogelman AM, Lusis AJ (1998) Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature 394, 284-287. (Pubitemid 28335041)
15. Bhattacharyya T, Nicholls SJ, Topol EJ, Zhang RL, Yang X, Schmitt D, Fu XM, Shao MY, Brennan DM, Ellis SG, Brennan ML, Allayee H, Lusis AJ, Hazen SL (2008) Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk. JAMA 299, 1265-1276. (Pubitemid 351439073)
16. Jakubowski H (2002) Homocysteine is a protein amino acid in humans. Implications for homocysteine-linked disease. J Biol Chem 277, 30425-30428. (Pubitemid 34970732)
17. Ishimine N, Usami Y, Nogi S, Sumida T, Kurihara Y, Matsuda K, Nakamura K, Yamauchi K, Okumura N, Tozuka M (2010) Identification of N-homocysteinylated apolipoprotein AI in normal human serum. Ann Clin Biochem 47, 453-459.
18. Ferretti G, Bacchetti T, Marotti E, Curatola G (2003) Effect of homocysteinylation on human high-density lipoproteins: A correlation with paraoxonase activity. Metabolism 52, 146-151. (Pubitemid 36388834)
19. Dantoine TF, Debord J, Merle L, Lacroix-Ramiandrisoa H, Bourzeix L, Charmes JP (2002) Paraoxonase 1 activity: A new vascular marker of dementia? Ann N Y Acad Sci 977, 96-101. (Pubitemid 35418140)
20. Paragh G, Balla P, Katona E, Seres I, Egerhazi A, Degrell I (2002) Serum paraoxonase activity changes in patients with Alzheimer's disease and vascular dementia. Eur Arch Psychiatry Clin Neurosci 252, 63-67. (Pubitemid 36056678)
21. Erlich PM, Lunetta KL, Cupples LA, Abraham CR, Green RC, Baldwin CT, Farrer LA (2010) Serum paraoxonase activity is associated with variants in the PON gene cluster and risk of Alzheimer disease. Neurobiol Aging, doi: 10.1016/j.neurobiolaging.2010.08.003.
22. Lacinski M, Skorupski W, Cieslinski A, Sokolowska J, Trzeciak WH, Jakubowski H (2004) Determinants of homocysteine-thiolactonase activity of the paraoxonase-1 (PON1) protein in humans. Cell Mol Biol 50, 885-893.
23. Wehr H, Bednarska-Makaruk M, Graban A, Lipczynska-Lojkowska W, Rodo M, Bochynska A, Ryglewicz D (2009) Paraoxonase activity and dementia. J Neurol Sci 283, 107-108.
24. Jakubowski H (2010) The role of paraoxonase 1 in the detoxification of homocysteine thiolactone. Adv Exp Med Biol 660, 113-127.
25. Sprince H, Parker CM, Josephs JA Jr, Magazino J (1969) Convulsant activity of homocysteine and other short-chain mercaptoacids: Protection therefrom. Ann N Y Acad Sci 166, 323-325.
26. Spence AM, Rasey JS, Dwyer-Hansen L, Grunbaum Z, Livesey J, Chin L, Nelson N, Stein D, Krohn KA, Ali-Osman F (1995) Toxicity, biodistribution and radioprotective capacity of L-homocysteine thiolactone in CNS tissues and tumors in rodents: Comparison with prior results with phosphoroth-ioates. Radiother Oncol 35, 216-226.
27. Folbergrova J (1997) Anticonvulsant action of both NMDA and non-NMDA receptor antagonists against seizures induced by homocysteine in immature rats. Exp Neurol 145, 442-450. (Pubitemid 27314795)
28. Rasic-Markovic A, Stanojlovic O, Hrncic D, Krstic D, Colovic M, Susic V, Radosavljevic T, Djuric D (2009) The activity of erythrocyte and brain Na+/K+ and Mg2+-ATPases in rats subjected to acute homocysteine and homocys-teine thiolactone administration. Mol Cell Biochem 327, 39-45.
29. Velez-Carrasco W, Merkel M, Twiss CO, Smith JD (2008) Dietary methionine effects on plasma homocysteine and HDL metabolism in mice. J Nutr Biochem 19, 362-370. (Pubitemid 351685662)
30. Chwatko G, Jakubowski H (2005) The determination of homocysteine- thiolactone in human plasma. Anal Biochem 337, 271-277. (Pubitemid 40187254)
31. Chwatko G, Jakubowski H (2005) Urinary excretion of homocysteine- thiolactoneinhumans. Clin Chem 51, 408-415.
32. Jakubowski H (2006) Mechanism of the condensation of homocysteine thiolactone with aldehydes. Chemistry 12, 8039-8043. (Pubitemid 44672724)
33. Jakubowski H (1997) Metabolism of homocysteine thio-lactone in human cell cultures. Possible mechanism for pathological consequences of elevated homocysteine levels. J Biol Chem 272, 1935-1942. (Pubitemid 27043288)
34. Jakubowski H, Zhang L, Bardeguez A, Aviv A (2000) Homo-cysteine thiolactone and protein homocysteinylationinhuman endothelial cells: Implications for atherosclerosis. Circ Res 87, 45-51. (Pubitemid 30456934)